Fangda advised AnHeart Therapeutics on the deal. Nuvation Bio Inc., a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and...
Nuvation Bio’s Acquisition of Shares in AnHeart
Kirin Holding’s $1 Billion Sale of a Stake in Joint Venture with China Resources
Fangda represented Kirin Holdings Company on the deal. Kirin Holdings Company executed the sale of its entire 40% stake in its joint venture with China Resources for...